Christopher T. Dunwiddie

4.9k total citations · 1 hit paper
38 papers, 3.5k citations indexed

About

Christopher T. Dunwiddie is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Christopher T. Dunwiddie has authored 38 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Genetics. Recurrent topics in Christopher T. Dunwiddie's work include Blood Coagulation and Thrombosis Mechanisms (19 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Venomous Animal Envenomation and Studies (8 papers). Christopher T. Dunwiddie is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (19 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Venomous Animal Envenomation and Studies (8 papers). Christopher T. Dunwiddie collaborates with scholars based in United States, Switzerland and United Kingdom. Christopher T. Dunwiddie's co-authors include Steven M. Paul, Bernard Munos, Stacy Lindborg, Aaron L. Schacht, Daniel S. Mytelka, Elka M. Nutt, George P. Vlasuk, G P Vlasuk, Anthony J. Faras and Robert J. Leadley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Christopher T. Dunwiddie

38 papers receiving 3.2k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

How to improve R&D productivity: the pharmaceutical industry's grand challenge

2010 2.3k citations Steven M. Paul, Daniel S. Mytelka et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher T. Dunwiddie United States	21	1.2k	847	461	405	388	38	3.5k
George P. Patrinos Greece	35	2.6k 2.1×	388 0.5×	1.3k 2.8×	242 0.6×	102 0.3×	303	6.6k
Asher Mullard Canada	53	4.9k 4.0×	870 1.0×	264 0.6×	433 1.1×	164 0.4×	604	9.9k
Philippe Sanséau United Kingdom	23	3.0k 2.5×	1.3k 1.6×	69 0.1×	130 0.3×	128 0.3×	46	5.5k
John Arrowsmith United Kingdom	13	1.3k 1.1×	835 1.0×	27 0.1×	310 0.8×	282 0.7×	19	3.3k
Alan Norris United Kingdom	16	1.6k 1.3×	891 1.1×	69 0.1×	86 0.2×	84 0.2×	29	3.9k
Patrick A. Eyers United Kingdom	40	4.9k 4.0×	1.1k 1.2×	153 0.3×	85 0.2×	135 0.3×	97	7.6k
David Cavalla United States	14	1.6k 1.4×	939 1.1×	44 0.1×	122 0.3×	85 0.2×	30	3.4k
Scott D. Patterson United States	47	4.9k 4.0×	129 0.2×	228 0.5×	164 0.4×	178 0.5×	219	11.0k
Gideon M. Blumenthal United States	47	2.4k 2.0×	110 0.1×	310 0.7×	443 1.1×	81 0.2×	119	7.5k
Ruth March United Kingdom	14	567 0.5×	359 0.4×	54 0.1×	197 0.5×	101 0.3×	29	2.1k

Countries citing papers authored by Christopher T. Dunwiddie

Since Specialization

Citations

This map shows the geographic impact of Christopher T. Dunwiddie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher T. Dunwiddie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher T. Dunwiddie more than expected).

Fields of papers citing papers by Christopher T. Dunwiddie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher T. Dunwiddie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher T. Dunwiddie. The network helps show where Christopher T. Dunwiddie may publish in the future.

Co-authorship network of co-authors of Christopher T. Dunwiddie

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher T. Dunwiddie. A scholar is included among the top collaborators of Christopher T. Dunwiddie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher T. Dunwiddie. Christopher T. Dunwiddie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paul, Steven M., Daniel S. Mytelka, Christopher T. Dunwiddie, et al.. (2010). How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Reviews Drug Discovery. 9(3). 203–214. 2338 indexed citations breakdown →

Guertin, Kevin R., Scott I. Klein, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity. Bioorganic & Medicinal Chemistry Letters. 12(12). 1671–1674. 45 indexed citations

Klein, Scott I., Kevin R. Guertin, Allison L. Zulli, et al.. (2002). Optimization of the β-Aminoester class of factor Xa inhibitors. part 1: P4 and side-Chain modifications for improved In vitro potency. Bioorganic & Medicinal Chemistry Letters. 12(12). 1667–1670. 14 indexed citations

Chu, Valeria, Karen Brown, Dennis Colussi, et al.. (2000). In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737. Thrombosis Research. 99(1). 71–82. 16 indexed citations

Klein, Scott I., Bruce F. Molino, Valeria Chu, et al.. (1998). Design of a New Class of Orally Active Fibrinogen Receptor Antagonists. Journal of Medicinal Chemistry. 41(14). 2492–2502. 15 indexed citations

Klein, Scott I., Kevin R. Guertin, Daniel L. Cheney, et al.. (1998). Identification and Initial Structure−Activity Relationships of a Novel Class of Nonpeptide Inhibitors of Blood Coagulation Factor Xa. Journal of Medicinal Chemistry. 41(4). 437–450. 35 indexed citations

Klein, Scott I., Bruce F. Molino, Robert J. Leadley, et al.. (1996). Non-peptide fibrinogen receptor antagonists based upon a 4-substituted piperidine scaffold. Bioorganic & Medicinal Chemistry Letters. 6(12). 1403–1408. 3 indexed citations

Klein, Scott I., Jeffrey M. Dener, Bruce F. Molino, et al.. (1996). O-benzyl hydroxyproline as a bioisostere for Phe-Pro: Novel dipeptide thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 6(18). 2225–2230. 10 indexed citations

Schultz, Loren D., Henry Z. Markus, Kathryn J. Hofmann, et al.. (1994). Using Molecular Genetics to Improve the Production of Recombinant Proteins by the Yeast Saccharomyces cerevisiae. Annals of the New York Academy of Sciences. 721(1). 148–157. 28 indexed citations

10.

Lynch, J J, Michael J. Mellott, Elka M. Nutt, et al.. (1994). Maintenance of canine coronary artery patency following thrombolysis with front loaded plus low dose maintenance conjunctive therapy. A comparison of factor Xa versus thrombin inhibition. Cardiovascular Research. 28(1). 78–85. 33 indexed citations

11.

Dunwiddie, Christopher T., Lloyd Waxman, George P. Vlasuk, & Paul A. Friedman. (1993). [18] Purification and characterization of inhibitors of blood coagulation factor Xa from hematophagous organisms. Methods in enzymology on CD-ROM/Methods in enzymology. 223. 291–312. 14 indexed citations

12.

Zacharski, Leo R., Forst E. Brown, Vincent A. Memoli, et al.. (1992). Pathways of coagulation activation in situ in rheumatoid synovial tissue. Clinical Immunology and Immunopathology. 63(2). 155–162. 50 indexed citations

13.

Schaffer, L W, et al.. (1992). Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 12(8). 879–885. 34 indexed citations

14.

Mellott, Michael J., Marie A. Holahan, Joseph J. Lynch, G P Vlasuk, & Christopher T. Dunwiddie. (1992). Acceleration of recombinant tissue-type plasminogen activator-induced reperfusion and prevention of reocclusion by recombinant antistasin, a selective factor Xa inhibitor, in a canine model of femoral arterial thrombosis.. Circulation Research. 70(6). 1152–1160. 29 indexed citations

15.

Dunwiddie, Christopher T., Michael P. Neeper, Elka M. Nutt, et al.. (1992). Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites. Biochemistry. 31(48). 12126–12131. 30 indexed citations

16.

Przysiecki, Craig T., Joseph G. Joyce, Paul M. Keller, et al.. (1992). Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae. Protein Expression and Purification. 3(3). 185–195. 13 indexed citations

17.

Zacharski, Leo R., Christopher T. Dunwiddie, Elka M. Nutt, Jane Hunt, & Vincent A. Memoli. (1991). Cellular Localization of Activated Factor X by Xa-Specific Probes. Thrombosis and Haemostasis. 65(5). 545–548. 23 indexed citations

18.

Dunwiddie, Christopher T., Donna Smith, Elka M. Nutt, & George P. Vlasuk. (1991). Anticoagulant effects of the selective factor Xa inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibition. Thrombosis Research. 64(6). 787–794. 23 indexed citations

19.

Nutt, Elka M., Deepak Kumar Jain, A. B. Lenny, et al.. (1991). Purification and characterization of recombinant antistasin: A leech-derived inhibitor of coagulation factor Xa. Archives of Biochemistry and Biophysics. 285(1). 37–44. 52 indexed citations

20.

Dunwiddie, Christopher T., et al.. (1986). Molecular cloning and characterization of gag-, pol-, and env-related gene sequences in the ev- chicken. Journal of Virology. 59(3). 669–675. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact